Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous levonorgestrel + ethinyl estradiol for premenstrual dysphoric disorder
2004-005173-27Phase 3Completed
- Sponsor
- Wyeth
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Premenstrual Dysphoric Disorder (PMDD) comparing Levonorgestrel + ethinyl estradiol continuous daily regimen with Placebo (2 arms). Primary endpoints: Mean change in DRSP 21-item total daily score from baseline to cycle 1 efficacy period and Mean change in DRSP 21-item total daily score from baseline to last on-therapy efficacy period. Started Jun 2005; status: completed.
02
Drugs
avatrombopagethinyl estradiol
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on 2004-005173-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005173-27.